Hywin Holdings Ltd ADR is an asset management business based in the US. Hywin Holdings Ltd ADR shares (HYW) are listed on the NASDAQ and all prices are listed in US Dollars. Hywin Holdings Ltd ADR employs 2,284 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $6.75 |
|---|---|
| 52-week range | $5.15 - $7.90 |
| 50-day moving average | $6.79 |
| 200-day moving average | $6.33 |
| Wall St. target price | $11.99 |
| PE ratio | 6.6569 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.02 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.75 from 2022-07-05
| 1 week (2022-06-29) | 6.75 |
|---|---|
| 1 month (2022-06-07) | 1.96% |
| 3 months (2022-04-07) | -10.12% |
| 6 months (2022-01-07) | 19.26% |
| 1 year (2021-07-06) | -10.12% |
|---|---|
| 2 years (2020-07-03) | N/A |
| 3 years (2019-07-03) | N/A |
| 5 years (2017-07-03) | N/A |
Valuing Hywin Holdings Ltd ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hywin Holdings Ltd ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Hywin Holdings Ltd ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Hywin Holdings Ltd ADR shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Hywin Holdings Ltd ADR's P/E ratio is best considered in relation to those of others within the asset management industry or those of similar companies.
Hywin Holdings Ltd ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $284.3 million.
The EBITDA is a measure of a Hywin Holdings Ltd ADR's overall financial performance and is widely used to measure a its profitability.
To put Hywin Holdings Ltd ADR's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1.8 billion |
|---|---|
| Operating margin TTM | 14.03% |
| Gross profit TTM | $1.8 billion |
| Return on assets TTM | 11.99% |
| Return on equity TTM | 32.42% |
| Profit margin | 10.52% |
| Book value | $28.38 |
| Market capitalisation | $190.1 million |
TTM: trailing 12 months
We're not expecting Hywin Holdings Ltd ADR to pay a dividend over the next 12 months.
You may also wish to consider:
Hywin Holdings Ltd. , through its subsidiaries, provides wealth management, insurance brokerage, and asset management service in China. It distributes private market investment products comprising asset-backed products, such as real estate securitization products, and equity investments in real estate projects or private project companies; venture capital, private equity, and hedge funds; and supply chain financing products, cash management products, and funds managed by its subsidiaries. The company also offers public market investment products, including money market funds, such as government bonds, central bank bills, term deposits, certificates of deposits, and corporate commercial papers; government bonds, corporate bonds, convertible bonds, and other traded debt instruments; and equities and multi-strategy funds. In addition, it provides individual whole life insurance, individual term life insurance, universal life insurance, individual health insurance, and annuity insurance products, as well as critical illness insurance comprising personal accident insurance products; discretionary and advisory mandates to ultra-high-net-worth clients; and overseas property investment services for residential properties, as well as client referrals to overseas property developers. Further, the company manages and distributes a range of private funds to professional investors; and offers information technology services, including transaction process management, data analysis, and system maintenance services to asset management service and financial product providers. The company was founded in 2006 and is headquartered in Shanghai, China.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.